Skip to content
The Policy VaultThe Policy Vault

Jakafi — Medical Mutual

Myelodysplastic Syndrome/Myeloproliferative Neoplasm (MDS/MPN) Overlap Neoplasms

Initial criteria

  • Chronic disease
  • Prescribed by or in consultation with a hematologist or oncologist

Approval duration

1 year